Dr Joshua Lehr J.Lehr@salford.ac.uk
Lecturer
Kidscan placement studentship 2024-25 (Lehr)
People Involved
Project Description
Acute leukaemia is a common form of childhood cancer.1 Treatment of acute leukaemia generally involves multidrug treatment protocols, which have dramatically increased survival rates from 10% several decades ago to over 65% today.2, 3 However, such treatments can often have long-lasting debilitating impacts.4 One drug that is a cornerstone of childhood leukaemia is the chemotherapy drug asparaginase. However, asparaginase treatment can have severe side effects such as anaphylactic shock. Asparaginase antibodies (anti-asparaginase) usually present themselves in the blood prior to such adverse effects. These are currently only monitored by enzyme-linked immunosorbent assays (ELISA) which cannot be employed for high frequency, real-time, monitoring of patient status.5 Electrochemical sensors are able, in principle, to monitor antibody levels in real time.
| Type of Project | Research Grant |
|---|---|
| Status | Project Live |
| Funder(s) | KidsCan |
| Value | £3,000.00 |
| Project Dates | Jun 1, 2024 - Sep 30, 2025 |
You might also like
Kidscan Placement Student Grant Scheme 2021-2022 Sep 1, 2021 - Sep 1, 2022
Kidscan Placement Student Grant Scheme Sep 1, 2020 - Sep 1, 2021
Electrochemical Sensors for Leukaemia Prognostics Jul 1, 2019 - Jul 1, 2020
Kidscan Student Placements 2022/23 Oct 1, 2022 - Sep 30, 2023
Supramolecular pattering of multifunctional interfaces from radical grafting reactions Mar 20, 2024 - Mar 19, 2025
The ability the create interfaces comprising multiple chemical functionalities that are spatially arranged on the nanoscale in a well-defined and predetermined manner has applications in a wide range of fields. Here we aim to use supramolecular archi...
Read More about Supramolecular pattering of multifunctional interfaces from radical grafting reactions.